Research Article
Anatomical and Functional Outcomes of Vitrectomy with/without Intravitreal Methotrexate Infusion for Management of Proliferative Vitreoretinopathy Secondary to Rhegmatogenous Retinal Detachment
Table 3
MTX versus mean visual acuity in each subgroup and no MTX use versus mean visual acuity in control.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
BCVA, best-corrected visual acuity; MTX, methotrexate; PVR, proliferative vitreoretinopathy; SD, standard deviation. is significant at <0.05. |